- Home
- FOUR vs BLCO Comparison
FOUR vs BLCO Comparison
Compare FOUR & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOUR
- BLCO
- Stock Information
- Founded
- FOUR 1999
- BLCO 1853
- Country
- FOUR United States
- BLCO Canada
- Employees
- FOUR N/A
- BLCO N/A
- Industry
- FOUR Business Services
- BLCO Ophthalmic Goods
- Sector
- FOUR Consumer Discretionary
- BLCO Health Care
- Exchange
- FOUR Nasdaq
- BLCO Nasdaq
- Market Cap
- FOUR 4.5B
- BLCO 4.0B
- IPO Year
- FOUR 2020
- BLCO 2022
- Fundamental
- Price
- FOUR $76.74
- BLCO $12.06
- Analyst Decision
- FOUR Buy
- BLCO Hold
- Analyst Count
- FOUR 24
- BLCO 12
- Target Price
- FOUR $107.55
- BLCO $18.64
- AVG Volume (30 Days)
- FOUR 1.8M
- BLCO 939.1K
- Earning Date
- FOUR 04-29-2025
- BLCO 04-30-2025
- Dividend Yield
- FOUR N/A
- BLCO N/A
- EPS Growth
- FOUR 112.80
- BLCO N/A
- EPS
- FOUR 3.03
- BLCO N/A
- Revenue
- FOUR $3,330,600,000.00
- BLCO $4,791,000,000.00
- Revenue This Year
- FOUR $25.71
- BLCO $6.30
- Revenue Next Year
- FOUR $15.02
- BLCO $5.56
- P/E Ratio
- FOUR $25.31
- BLCO N/A
- Revenue Growth
- FOUR 29.86
- BLCO 15.56
- 52 Week Low
- FOUR $55.87
- BLCO $10.46
- 52 Week High
- FOUR $127.50
- BLCO $21.69
- Technical
- Relative Strength Index (RSI)
- FOUR 39.80
- BLCO 38.44
- Support Level
- FOUR $76.35
- BLCO $11.62
- Resistance Level
- FOUR $79.35
- BLCO $12.38
- Average True Range (ATR)
- FOUR 4.90
- BLCO 0.89
- MACD
- FOUR 0.44
- BLCO -0.03
- Stochastic Oscillator
- FOUR 48.51
- BLCO 37.74
About FOUR Shift4 Payments Inc.
Shift4 Payments Inc is provider of integrated payment processing and technology solutions. The company offers software providers a single integration to an end-to-end payments offering, a powerful gateway and a robust suite of technology solutions (including cloud enablement, business intelligence, analytics, and mobile) to enhance the value of their software suites and simplify payment acceptance. The company derives maximum revenue from United States.
About BLCO Bausch + Lomb Corporation
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.